Report explores new opportunities for chronic pain research

1st Dec 2022

A report, Chronic pain: experimental medicine and clinical insights, has been released today from a workshop jointly hosted by the British Neuroscience Association (BNA), the Academy of Medical Sciences, the Physiological Society and Versus Arthritis.

The chronic pain workshop was held in December 2021 after being rescheduled from 2020 due to COVID 19. It was a central element of the BNA’s previous Neuroscience of Pain annual theme for 2020 and remains a key output of that year’s focus.

This workshop was chaired by Professor Irene Tracey, Nuffield Department of Clinical Neuroscience, University of Oxford and Dr Iain Chessell, AstraZeneca and explored the current landscape of translational chronic pain research and considered how clinical research, through experimental medicine, clinical insights and patient experience, can help provide new evidence sources to inform preclinical drug discovery.

The key objectives of the workshop were to:

• Explore how insights from clinical research can provide new opportunities to inform drug discovery programmes (and other therapeutic interventions) to overcome the translational challenges of chronic pain research.
• Consider how cross-sector collaboration, knowledge exchange and strategic coordination between sectors can enable the potential of such insights to be realised.

You can read the full report via the Academy of Medical Sciences website.